CD1D and malignant colon neoplasm: Furthermore, cancer cells can downregulate CD1d surface expression, thereby limiting direct recognition by iNKT cells (55–57), even though they have shown to kill by perforin and/or granzymes at least colon cancer cells also in a CD1d-independent manner (58).